Quick Search Form

Book Title: Treating and Preventing Adolescent Mental Health Disorders  > pp. [664]
Click here to open a preview window containing the current page in a printer-friendly form Printer Friendly   go to page    previous  |  next

 
man, E., Robinson, D., et al. (2001). Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry, 49, 487–499.
Lieberman, J. A., Gu, H., Stroup, S., Zhang, P., Kong, L., Ji, Z., et al. (2003). Atypical and conventional antipsychotic drugs in first episode schizophrenia: Comparison of clozapine versus chlorpromazine in a 52-week randomized double-blind trial. Neuropsychopharmacology, 28, 995–1003.
Lieberman, J., Jody, D., Geisler, S., Alvir, J., Loebel, A., Szymanski, S., et al. (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry, 50, 369–376.
Linnoila, M., & Viukari, M. (1979). Sodium valproate and tardive dyskinesia. British Journal of Psychiatry, 134, 223–224.
Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273–279.
Linszen, D., Dingemans, P., Van der Does, J. W., Nugter, A., Scholte, P., Lenoir, R., et al. (1996). Treatment, expressed emotion and relapse in recent onset schizophrenic disorders. Psychological Medicine, 26, 333–342.
Lohr, J. B., & Flynn, K. (1993). Minor physical anomalies in schizophrenia and mood disorders. Schizophrenia Bulletin, 19, 551–556.
Loiselle, D., Stamm, J., Maitinsky, S., & Whipple, S. (1980). Evoked potential and behavioral signs of attention dysfunction in hyperactive boys. Psychophysiology, 17, 193–201.
Malmberg, A., Lewis, G., David, A., & Allebeck, P. (1998). Premorbid adjustment and personality in people with schizophrenia. British Journal of Psychiatry, 172, 308–313.
Manschreck, T. C., Maher, B. A., Rucklos, M. E., & Vereen, D. R. (1982). Disturbed voluntary motor activity in schizophrenic disorder. Psychological Medicine, 12, 73–84.
Marcus, J., Hans, S., Auerbach, J., & Auerbach, A. (1993). Children at risk for schizophrenia: The Jerusalem Infant Development Study: II. Neurobehavioral deficits at school age. Archives of General Psychiatry, 50, 797–809.
Marcus, J., Hans, S., Nagler, S., Auerbach, J., Mirsky, A., & Aubrey, A. (1987). Review of the NIMH Israeli Kibbutz-city study and the Jerusalem Infant Development Study. Schizophrenia Bulletin, 13, 425–438.
May, P. R., Tuma, A. H., Yale, C., Potepan, P., & Dixon, W. J. (1976). Schizophrenia—a follow-up study of results of treatment. Archives of General Psychiatry, 33, 481–486.
McCarley, R. W., Hsiao, J. K., Freedman, R., Pfefferbaum, A., & Donchin, E. (1996). Neuroimaging and the cognitive neuroscience of schizophrenia. Schizophrenia Bulletin, 22, 703–725.
McCarley, R. W., Shenton, M. E., O'Donnell, B. F., Faux, S. F., Kikinis, R., Nestor, P. G., et al. (1993). Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Archives of General Psychiatry, 50, 190–197.
McCreadie, R. G., Wiles, D., Grant, S., Crockett, G. T., Mahmood, Z., Livingston, M. G., et al. (1989). The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group. Acta Psychiatrica Scandinavica, 80, 597–602.
McEvoy, J. P., Hogarty, G. E., & Steingard, S. (1991). Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry, 48, 739–745.
end p.664
  go to page    previous  |  next

 
-->
Contents
 
scroll up fast
scroll up
 
scroll down
scroll down fast

Return to Top